SEC Comment Letter for IMMUTEP Ltd (IMMP, PRRUF) (CIK 0001506184) (IMMP) — Oct 27, 2017
IMMUTEP Ltd (IMMP, PRRUF) (CIK 0001506184)
Date: Oct. 27, 2017 · CIK: 0001506184 · Accession: 0000000000-17-038139
AI Filing Summary & Sentiment
Letter
October 27, 2017 Marc Voigt Chief Executive Officer Prima BioMed Ltd Level 12, 95 Pitt Street Sydney, 2000 New South Wales Australia Prima BioMed Ltd Registration Statement on Form F-3 Filed October 19, 2017 File No. 333-221021Re: Dear Mr. Voigt: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Dorrie Yale at 202-551-8776 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Christopher H. Cunningham
Show Raw Text
October 27, 2017
Marc Voigt
Chief Executive Officer
Prima BioMed Ltd
Level 12, 95 Pitt Street
Sydney, 2000 New South Wales
Australia
Prima BioMed Ltd
Registration Statement on Form F-3
Filed October 19, 2017
File No. 333-221021Re:
Dear Mr. Voigt:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Dorrie Yale at 202-551-8776 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Christopher H. Cunningham